| Date Filed | Type | Description |
| 02/11/2015 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2015 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 0% stake in AVANIR PHARMACEUTICALS INC |
| 02/09/2015 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 12.1% stake in AVANIR PHARMACEUTICALS INC |
| 01/26/2015 |
SC 13G/A
| BlackRock Inc. reports a 7.5% stake in AVANIR PHARMACEUTICALS INC |
| 01/13/2015 |
8-K
| Quarterly results |
| 01/13/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/12/2015 |
SC 13G/A
| FMR LLC reports a 2.4% stake in AVANIR PHARMACEUTICALS |
| 01/06/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/05/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/31/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/22/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2014 |
4
| OCAMPO CHRISTINE (Vice President, Finance) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC. |
| 12/18/2014 |
4
| Katkin Keith (President and CEO) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $16.95, valued at
$339k
Sold 195,160 shares
@ $16.95, valued at
$3.3M
Sold 62,520 shares
@ $16.93, valued at
$1.1M
Exercised 55,960 options to buy
@ $1.29, valued at
$72.2k
Exercised 139,200 options to buy
@ $1.74, valued at
$242.2k
|
|
| 12/12/2014 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 12/12/2014 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 12/11/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/10/2014 |
10-K
| Annual Report for the period ended September 30, 2014 |
| 12/10/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/02/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/02/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/02/2014 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 12/02/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 11/28/2014 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 15,000 shares
@ $15, valued at
$225k
Exercised 15,000 options to buy
@ $3.38, valued at
$50.7k
|
|
| 11/26/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/12/2014 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 59,231 shares
@ $0
Granted 34,825 shares
@ $0 |
|
| 11/12/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC. |
| 11/12/2014 |
4
| Katkin Keith (President and CEO) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 220,563 shares
@ $0
Granted 140,611 shares
@ $0 |
|
| 11/12/2014 |
4
| OCAMPO CHRISTINE (Vice President, Finance) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC. |
| 11/12/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/10/2014 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 17% stake in Avanir Pharmaceuticals, Inc. |
| 11/10/2014 |
SC 13G/A
| FMR LLC reports a 10.8% stake in AVANIR PHARMACEUTICALS |
| 11/07/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/24/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC. |
| 10/24/2014 |
4
| Katkin Keith (President and CEO) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 27,567 shares
@ $11.76, valued at
$324.2k
|
|
|